HomeOfferingsAboutReferencesSpeakingInsightsContact
|
Request orientation call

Public References

Trust grows when complex biology becomes verifiable.

A curated selection of public sources covering science, BioVariance, media, talks, regional visibility, and current longevity work.

50+

scientific publications

2,000+

scientific citations

2013

BioVariance founded

TOP 100

innovation context

100+

public traces and references

Evidence map

Five Lines of Evidence

01

Scientific foundation

Bioinformatics, pharmaceutical data analysis, and complex biomedical systems form the foundation.

02

Entrepreneurial experience

BioVariance translated data-driven diagnostics, multi-omics, and personalized medicine into an operating company.

03

Media and interviews

Regional, specialist, and business media have covered the work from different angles over many years.

04

Networks and recognition

TOP 100, Medical Valley, BioPark, and regional ambassador roles show resonance beyond this website.

05

Longevity without hype

Current work turns biomarkers, aging biology, and prevention into realistic next decisions.

Milestone path connecting regional roots, biomedical data, networks, and renewed longevity focus
The reference page is not a logo strip. It maps a public trail: science, company building, media, region, networks, and transparent learning.

Selected sources

Curated Highlights

A deliberately small selection of the strongest sources before the full reference library.

Layered research documents connected to a scientific network
Scientific trace: Public profiles, publications, presentations, and data work form the verifiable scientific layer.
Abstract media resonance map with articles, audio, and video signals
Public resonance: Articles, interviews, videos, podcasts, and talks show how the work has been interpreted externally.

Reference library

Reference Library

Grouped by trust logic rather than alphabetically: science, company history, media, region, stage, and current work.

38 curated links6 categoriespublic sources only

06

Longevity & aktuelle Arbeit

Aktuelle öffentliche Spuren zu Longevity, Biomarkern und Prävention.

Context

Transparency matters

BioVariance's history also includes a restructuring and insolvency phase. I do not frame this as a blemish, but as part of real innovation work: science, technology, and business model have to become structurally viable. That experience now informs the focus on clear decision logic, realistic implementation, and robust structures.

How can this experience become useful for your question?

If you want to explore how multiomics, biomarkers, prevention, health-tech, or workplace health can turn data into decisions, an orientation call is the smallest useful next step.

Request orientation call
Stay connected

No spam. Just a personal note when something new appears.

Request orientation call